Azim, Hamdy <br/><br/>
Targeting RANKL in breast cancer: bone metastasis and beyond.  [electronic resource] 

 -  Expert review of anticancer therapy  Feb 2013 
 - 195-201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/era.12.177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--pathology<br/>Denosumab<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Osteoclasts--metabolism<br/>Osteoporosis, Postmenopausal<br/>RANK Ligand--antagonists & inhibitors<br/>Receptor Activator of Nuclear Factor-kappa B--metabolism